Aardvark Therapeutics, Inc. (AARD)
NASDAQ · Healthcare
Aardvark Therapeutics, Inc. annual/quarterly shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aardvark Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were 106.6M, a 295.14% decrease year-over-year.
- Aardvark Therapeutics, Inc. shareholder equity for 2025 were 106.6M, a 295.14% decrease from 2024.
- Aardvark Therapeutics, Inc. shareholder equity for 2024 were -54.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aardvark Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $107 |
| 2024 | $-55 |
| Aardvark Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $107 |
| 2024-12-31 | $-55 |
Aardvark Therapeutics, Inc. Shareholder Equity — FAQ
Aardvark Therapeutics, Inc. (AARD) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AARD's shareholder equity history?
The chart and table above show Aardvark Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.